🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

9+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 9 of 9 recruiting trials for “familial-nonmedullary-thyroid-carcinoma”

Phase 2Enrolling by InvitationNCT07344220 ↗

Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate

👨‍⚕️ Carlos Becerra, MD, Hoag Memorial Hospital Presbyterian📍 1 site📅 Started Jan 2026View details ↗
NARecruitingNCT07068542 ↗

Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer

👨‍⚕️ Minghua Ge, Zhejiang Provincial People's Hospital📍 1 site📅 Started Jul 2025View details ↗
Phase 3RecruitingNCT06860971 ↗

A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma

🏥 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.📍 35 sites📅 Started Apr 2025View details ↗
NAEnrolling by InvitationNCT06744595 ↗

Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer

👨‍⚕️ Adrianna D. Clapp, MD, Mayo Clinic📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06440850 ↗

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation

👨‍⚕️ Sasan Fazeli, City of Hope Medical Center📍 1 site📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT06359847 ↗

Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer

👨‍⚕️ Yansong Lin, Ph D, Peking Union Medical College Hospital📍 1 site📅 Started Nov 2023View details ↗
RecruitingNCT05994365 ↗

Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma

🏥 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.📍 3 sites📅 Started Aug 2023View details ↗
RecruitingNCT04743479 ↗

Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)

👨‍⚕️ Gang Jin, M.D., Department of general surgery, Changhai Hospital📍 1 site📅 Started Dec 2020View details ↗
RecruitingNCT01102569 ↗

Pancreatic Cancer Genetics

👨‍⚕️ Fay Kastrinos, MD, Columbia University📍 1 site📅 Started Jan 2008View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →